MedPath

Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients

Not Applicable
Recruiting
Conditions
Endocrinology
Type 2 Diabetes
Interventions
Device: Freestyle Libre 2
Other: Therapeutic education
Registration Number
NCT05676593
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Therapeutic patient education (TPE) is a key element in the management of people living with type 2 diabetes.

The benefit of therapeutic education (TPE) has been clearly established on glycaemic control.

Continuous interstitial glucose monitoring (CGM) can be considered as a TPE tool for people living with diabetes. A direct reading of the effects of diet and physical activity on glycaemic levels could have an impact on the initiation and maintenance of therapeutic lifestyle modifications.

The investigators therefore propose a prospective randomised study in 2 arms :

* a group of people living with diabetes receiving standard TPE vs

* a group of people living with diabetes receiving standard TPE + FSL 28 days Ourmain objective is to determine the benefit of CGM on HbA1c at 3 months between 2 arms

Detailed Description

Main objective to the investigators is to determine the benefit of continuous interstitial glucose monitoring (by fresstyle 2) for 28 days coupled with standard TPE (Patient Therapeutic Education) vs standard TPE alone in newly diagnosed type 2 diabetics on HbA1c at 3 months.

The secondary objectives are to evaluate the effect of the TPE coupled with FSL vs TPE alone on :

* HbA1c at 6 months (assessment of persistence or not of a remote effect)

* weight change at 3 and 6 months

* other cardiovascular risk factors : variation in blood pressure, lipid profil at 3 and 6 months

* eating behaviour/ eating habits at 3 and 6 months

* treatment satisfaction, anxiety and quality of life scores

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • recently diagnosed diabete mellitus (<1 an) treated by non medical therapeutics and/or metformine
  • > 18 years old
  • initial glycated hemoglobin between 7 and 8.5%
Exclusion Criteria
  • Person whose physical and/or psychological health is severely impaired
  • Person deprived of his rights, person under guardianship or curatorship
  • Person deprived of liberty (by judicial or administrative decision)
  • Person who does not speak the French language
  • Absence of affiliation to/Not beneficiary of a Social Security scheme
  • Absence of written informed consent to participate in the study
  • Unable to understand the nature, purpose and methodology of the study
  • Bariatric surgery planned within 6 months of inclusion

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
People living with diabete standard TPE + FSL 28 daysFreestyle Libre 2Continuous mesure of glucose (FSL2) during 28 days at enrollment Therapeutic education HBA1c at 3 and 6 months Auto questionnary on Aviitam plateform at 3 and 6 months Auto questionnary on Aviitam plateform at 3 and 6 months
People living with diabete standard TPE + FSL 28 daysTherapeutic educationContinuous mesure of glucose (FSL2) during 28 days at enrollment Therapeutic education HBA1c at 3 and 6 months Auto questionnary on Aviitam plateform at 3 and 6 months Auto questionnary on Aviitam plateform at 3 and 6 months
People living with diabete standard TPETherapeutic educationHBA1c at 3 and 6 months Therapeutic education Auto questionnary on Aviitam plateform at 3 and 6 months
Primary Outcome Measures
NameTimeMethod
Rate of change in glycated hemoglobine at 3 months3 months

biological control of glycated hemoglobin in a laboratory

Secondary Outcome Measures
NameTimeMethod
Concentration of of LDL cholesterolIn g/L each 3,6 months
Quality of Life questionnaryFrom 0 to 100 (100 good quality of life - 0 bad quality of life) performed at 3,6 months

EQ-5D - EuroQoL-5D

Rate of change in glycated hemoglobin at 6 months6 months

biological control

Rate of change arteriel pressureIn mmHg each 3,6 months
Rate of change of the time in range, time above range and time below range6 months

data of the freestyle libre

Rate of change in weight in kgIn kg each 3,6 months
Concentration of TriglycerideIn g/L each 3,6 months
Anxiety and depression scale questionnary14 questions (high score depression, anxiety - low score good health) performed at 3,6 months

HAD - Hospital Anxiety and Depression scale

Eating behavior questionnaire33 questions (no scale, doctor's assessment of the answers) performed at 3,6 months

DEBQ-Dutch Eating Behaviour Questionnaire

Trial Locations

Locations (1)

UHM Montpellier

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath